^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
ColoSense™

Company:
Geneoscopy
Type:
FDA Approved
Related tests:

Details

Evidence
ColoSense is the first noninvasive colorectal cancer screening test to provide a dynamic view of disease activity by using RNA biomarkers. ColoSense harnesses the power of RNA biomarkers to aid in the detection of colorectal cancer and advanced adenomas.
Cancer:
Colorectal Cancer
Method:
RNA-based molecular screening test
Approvals
Date
Cancer
Gene
Drug
By
05/06/24
FDA